These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II. Mavissakalian M, Turner SM, Michelson L, Jacob R. Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761 [Abstract] [Full Text] [Related]
10. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder. Austin LS, Lydiard RB, Ballenger JC, Cohen BM, Laraia MT, Zealberg JJ, Fossey MD, Ellinwood EH. Biol Psychiatry; 1991 Aug 01; 30(3):225-32. PubMed ID: 1832972 [Abstract] [Full Text] [Related]
11. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Ananth J, Pecknold JC, van den Steen N, Engelsmann F. Prog Neuropsychopharmacol; 1981 Aug 01; 5(3):257-62. PubMed ID: 7022517 [No Abstract] [Full Text] [Related]
12. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. Vallejo J, Olivares J, Marcos T, Bulbena A, Menchón JM. Br J Psychiatry; 1992 Nov 01; 161():665-70. PubMed ID: 1422616 [Abstract] [Full Text] [Related]
13. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. Fallon BA, Liebowitz MR, Campeas R, Schneier FR, Marshall R, Davies S, Goetz D, Klein DF. Arch Gen Psychiatry; 1998 Oct 01; 55(10):918-24. PubMed ID: 9783563 [Abstract] [Full Text] [Related]
14. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials. Bystritsky A, Waikar SV. J Nerv Ment Dis; 1994 Sep 01; 182(9):485-7. PubMed ID: 8083675 [Abstract] [Full Text] [Related]
16. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL. Arch Gen Psychiatry; 1988 Feb 01; 45(2):167-72. PubMed ID: 3276283 [Abstract] [Full Text] [Related]
17. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD. Arch Gen Psychiatry; 1989 Dec 01; 46(12):1088-92. PubMed ID: 2686576 [Abstract] [Full Text] [Related]
18. Drug treatment of obsessive-compulsive disorder. Zohar J, Insel TR. J Affect Disord; 1987 Dec 01; 13(2):193-202. PubMed ID: 2960711 [Abstract] [Full Text] [Related]
19. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL. Am J Psychiatry; 1988 Dec 01; 145(12):1521-5. PubMed ID: 3057923 [Abstract] [Full Text] [Related]
20. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, Linnoila M. Arch Gen Psychiatry; 1985 Oct 01; 42(10):977-83. PubMed ID: 3899048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]